Phar­ma in the crosshairs: How the FTC is ex­pand­ing its an­titrust pow­ers un­der its new chair

4 years ago
Pharma

Cure­Vac gains COO and hands Flo­ri­an von der Mülbe new as­sign­ment in the midst of Covid-19 vac­cine trou­bles; As Ken ...

4 years ago
Peer Review

Hal Bar­ron's chase for ge­net­ic clues leads Glax­o­SmithK­line back to neu­ro — and makes new biotech part­ner $700M ...

4 years ago
Deals

The class of mol­e­cules be­hind one of biotech's biggest Alzheimer's fail­ures gets a new lease on life

4 years ago
Deals
R&D

Evotec ex­pands pres­ence in Italy with ac­qui­si­tion of for­mer Glax­o­SmithK­line R&D site

4 years ago
R&D
Outsourcing

Scoop: Am­gen re­cruits renowned can­cer drug in­ves­ti­ga­tor Jean-Charles So­ria to lead a grow­ing pipeline play

4 years ago
People

Sir­naomics puts off an IPO a lit­tle longer as it pock­ets an­oth­er megaround. Is an S-1 around the cor­ner this time?

4 years ago
Financing
China

Mer­ck to with­draw dan­gling ac­cel­er­at­ed ap­proval for Keytru­da in third-line stom­ach can­cer

4 years ago
R&D
FDA+

Years af­ter bank­rupt­cy, Den­dreon adds a con­tract man­u­fac­tur­ing wing

4 years ago
Outsourcing
Manufacturing

Covid-19 man­u­fac­tur­ing roundup: In­dia starts man­u­fac­tur­ing of No­vavax vac­cine — re­port; US ships spare shots to ...

4 years ago
Coronavirus
Manufacturing

WuXi will add 500 jobs at Delaware man­u­fac­tur­ing cam­pus as it looks to bol­ster its CD­MO arm

4 years ago
Outsourcing
Manufacturing

New to the par­ty, No­var­tis seeks to plunge in­to mR­NA

4 years ago
R&D

Kin­tara of­fers peek at mid-stage da­ta in re­lapsed glioblas­toma pa­tients; Jazz wins quick ap­proval for pe­di­atric ...

4 years ago
News Briefing

Mer­ck ex­tends deal to see what else NG­M's dis­cov­ery en­gine can come up with

4 years ago
Deals

Vet­er­an amy­loid cham­pi­on helps Alzheimer's start­up grab $160M in IPO as in­vestors charge back in to a once fad­ed ...

4 years ago
Financing
R&D

Roche mulling quick fil­ing for a tar­nished Alzheimer’s drug as con­tro­ver­sial Aduhelm OK elec­tri­fies the field — ...

4 years ago
R&D
FDA+

Roche reach­es out once again for the bud­get ax with plans to chop up to 400 de­vel­op­ment jobs in R&D

4 years ago
R&D
Pharma

Catal­ent bags a Ger­man stem cell de­vel­op­er to build its next-gen ther­a­peu­tics wing

4 years ago
R&D
Outsourcing

A vi­ral vec­tor play­er is ex­pand­ing its foot­print in Basque Coun­try amid height­ened de­mand

4 years ago
Outsourcing
Manufacturing

Fu­ji­film out­lays whop­ping $850M for its Diosynth CM­DO wing, look­ing to rapid­ly scale cell cul­ture pro­duc­tion

4 years ago
Outsourcing
Manufacturing

Hori­zon takes the leap in­to man­u­fac­tur­ing, buy­ing out an Irish plant with around 40 em­ploy­ees in tow

4 years ago
Outsourcing
Manufacturing

Nestlé is bet­ting $525M on a bid to pi­o­neer world's first mi­cro­bio­me drug

4 years ago
Deals

Covid-19 roundup: Cure­Vac push­es ahead for vac­cine au­tho­riza­tion de­spite fail­ing to hit 50% ef­fi­ca­cy thresh­old

4 years ago
Coronavirus

Pfiz­er bets on Spero can­di­date, wad­ing deep­er along­side GSK and Roche in­to aban­doned an­tibi­ot­ic mar­ket

4 years ago
R&D
First page Previous page 681682683684685686687 Next page Last page
A service from the Financial Times